Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-05-28

Clinical Trial Update: Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT) [NA]

View source ↗

Summary

A completed prospective pilot study evaluating the use of Floseal for anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Floseal

Snippet

Sponsor: Unity Health Toronto | Conditions: Hereditary Hemorrhagic Telangiectasia (HHT), Epistaxis | NA | Status: COMPLETED | Results posted: 2020-05-28